MetaCap

Braveheart Bio (BRVE) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.67 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BRVE-31.58%TRAX-8.10%
+18%-13%-44%
Aug 6, 20261 yearNov 20, 2026
BRVE-32.03%TRAX-8.14%
+8%-16%-40%
Aug 3, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BRVE versus TRAX key metrics
MetricBRVETRAX
Share price$20.39$41.64
Market cap$1.67B$1.75B
1-day change+5.81%-6.34%
EPS (TTM)$-6.59$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$32.00$54.78
52-week low$16.70$14.72
Distance from 52-week high-36.28%-23.99%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+123.15%+80.52%
Average volume491.27K826.70K
Shares outstanding82.07M42.02M
Employees49104
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Braveheart Bio

BRVE stock →

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

About First Tracks Biotherapeutics

TRAX stock →

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees

BRVE vs TRAX FAQ

Which is bigger, Braveheart Bio or First Tracks Biotherapeutics?

First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.67B for Braveheart Bio (BRVE).

Are Braveheart Bio and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons